Patents and technology transfer in CRISPR technology.

Area of Science:

• Biotechnology
• Molecular Biology
• Intellectual Property Law

Background:

• CRISPR technology has significantly impacted biological research and commercial applications.
• Extensive patenting of CRISPR systems and applications by academic institutions and companies is evident.
• Startups and spin-out companies are actively commercializing CRISPR technologies.

Purpose of the Study:

• To discuss CRISPR nucleases and their diverse applications.
• To provide an expert perspective on the CRISPR patent and technology landscape, particularly for non-mammalian systems.
• To identify future advancements and potential challenges for CRISPR in non-mammalian systems.

Main Methods:

• Review of CRISPR nucleases and their established applications.
• Analysis of the current CRISPR patent and technology landscape for non-mammalian systems.
• Case study analysis of CRISPR diagnostics companies (SHERLOCK and Mammoth Biosciences) focusing on SARS-CoV-2 detection.

Main Results:

• CRISPR technology has a broad range of applications in agriculture, synthetic biology, bio-nanotechnology, and precision medicine.
• The patent landscape for CRISPR, especially in non-mammalian systems, presents both opportunities and challenges.
• CRISPR-based diagnostics companies are at the forefront of developing platforms for pathogen detection, exemplified by SARS-CoV-2 diagnostics.

Conclusions:

• CRISPR technology continues to evolve with significant commercial potential.
• Understanding the patent landscape is crucial for navigating CRISPR's future in non-mammalian systems.
• Future advancements in CRISPR for non-mammalian systems will likely focus on diagnostics and overcoming technological hurdles.